One of our challenges as a UVB Narrow Band supplier are Insurance Companies like AETNA that consider UVB NB to be “investigational” when used at home.Their Clinical Policy Bulletin CBP 0422 Policy dated 4/22/2011 reads “Aetna considers home phototherapy experimental and investigational for the treatment of vitiligo because there is a lack of evidence regarding the safety and effectiveness of home phototherapy for this condition.”
You can read the AETNA policy at their website:
AETNA should evaluate studies such as http://ajwin.us/vithappens.com/index.php/2010/08/narrow-band-uvb-phototherapy-in-150-patients-with-vitiligo/
This really is to put it mildly total crap! There are many studies showing that Vitiligo patients are helped with home phototherapy. Home users over the long run are typically more likely to be “compliant” because they don’t have to go to a clinic three times a week for a very short treatments over a very long time. The burden of visiting a clinic or doctor’s office week after week is costly, and many employers will not tolerate their employees interrupting their work day three times a week.
In a psoriasis study the conclusion by the authors was “Ultraviolet B phototherapy administered at home is equally safe and equally effective, both clinically and for quality of life, as ultraviolet B phototherapy administered in an outpatient setting. Furthermore, ultraviolet B phototherapy at home resulted in a lower burden of treatment and led to greaterpatients’ satisfaction.” In my years of experience, the same is true for people with Vitiligo. Read more at http://ajwin.us/vithappens.com/index.php/2010/07/comparing-home-to-outpatient-uvb-phototherapy
Let’s hope that AETNA and CIGNA that has a similar policy come out of the dark ages soon.